Spravato, the nasal spray from Janssen Pharmaceutica – a subsidiary of Johnson & Johnson -, can now be sold in the United States as a stand-alone treatment for depression. The spray contains esketamine, a relative of the anesthetic drug ketamine, and is only administered under medical supervision if other treatments for depression have not helped.
Stay informed
If you want to stay informed about everything surrounding the war in Ukraine, sign up for our stay informed newsletter.